Skip to main content
Clinical Trials/NCT02867787
NCT02867787
Unknown
Phase 2

Study of the Treatment of Tendinopathy Unruptured of Rotator Cuff by Intramuscular Injection of Botulinum Toxin

Versailles Hospital1 site in 1 country40 target enrollmentMarch 2014

Overview

Phase
Phase 2
Intervention
Botox arm
Conditions
Tendinopathy Rotator Cuff
Sponsor
Versailles Hospital
Enrollment
40
Locations
1
Primary Endpoint
Significant improvement in shoulder pain objectified by analogy Visual Scale (VAS) in patients with unruptured tendinopathy of the rotator cuff impingement, debilitating, lasting for more than 3 months and resistant to usual medical treatment.
Last Updated
9 years ago

Overview

Brief Summary

Botulinum toxin is used in musculoskeletal therapy routinely for 15 years. This is one of the most potent neurotoxins. It comes in 7 serotypes (A to G).Therapeutic application of botulinum toxin are mainly based on its ability to block the neuromuscular transmission by preventing the release of acetylcholine, creating paralysis muscle relative and reversible.

It has been used in the treatment of cervical dystonia, migraine headaches, and an antinociceptive effect. The analgesic effect occurred even prior to the release muscular. Several randomized studies have been published about it. The investigators assume that intramuscular injection of botulinum toxin is effective in the treatment of tendinopathy rotator cuff.

Registry
clinicaltrials.gov
Start Date
March 2014
End Date
September 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Versailles Hospital
Responsible Party
Principal Investigator
Principal Investigator

Nicolas Pujol

Investigator coordinator

Versailles Hospital

Eligibility Criteria

Inclusion Criteria

  • Signed consent
  • Active social care
  • Compliant patient with protocol
  • Patient more than 18 years
  • Positive Neer Test

Exclusion Criteria

  • Prior study exclusion period
  • Protected patient
  • Study refusal
  • Deficient patient
  • Rheumatoid arthritis, osteoarthritis, chondrocalcinosis.
  • Microcrystalline arthritis.
  • Active infection .
  • History of hypersensitivity reaction during a previous injection of botulinum toxin
  • Bilateral involvement
  • Neurological deficit

Arms & Interventions

Botox arm

intramuscular injection of botulinum toxin

Intervention: Botox arm

Outcomes

Primary Outcomes

Significant improvement in shoulder pain objectified by analogy Visual Scale (VAS) in patients with unruptured tendinopathy of the rotator cuff impingement, debilitating, lasting for more than 3 months and resistant to usual medical treatment.

Time Frame: 3 months

Secondary Outcomes

  • Significant improvement in life quality : functional clinical scores (Constant, ASES, Oxford)(24 months)

Study Sites (1)

Loading locations...

Similar Trials